Inhibitory effect of Aspergillus fumigatus extract on matrix metalloproteinases expression

Farshid Saadat1, Kamiar Zomorodian, Mohammad Pezeshki

  • 1Division of Biotechnology, Department of Pathobiology, School of Public Health and Institute of Public Health Research, Tehran University of Medical Sciences, P.O. Box: 14155-6446, Tehran, Iran.

Mycopathologia
|October 19, 2004
PubMed
Abstract

Insights

Aspergillus fumigatus extract inhibits matrix metalloproteinases (MMPs) production, showing lower cytotoxicity than other agents. This fungal extract may offer potential for developing anti-MMP cancer therapies.

Area of Science:

  • Biochemistry
  • Mycology
  • Cell Biology

Background:

  • Matrix metalloproteinases (MMPs) are implicated in physiological and pathological processes.
  • Evidence suggests MMPs play a role in the pathophysiology of fungal infections.

Purpose of the Study:

  • To investigate the effect of Aspergillus fumigatus somatic extract on MMPs production.
  • To compare the extract's influence with other fungal extracts and therapeutic agents.

Main Methods:

  • In vitro cytotoxicity assay using a Fibrosarcoma cell line.
  • Sodium dodecyl sulfate-polyacrylamide gel electrophoresis and gelatin zymography to analyze MMPs production.
  • Comparative analysis with steroidal and non-steroidal drugs.

Main Results:

  • Aspergillus fumigatus extract demonstrated dose-dependent inhibition of MMPs.
  • The fungal extract exhibited significantly lower cytotoxicity compared to other tested agents.
  • Comparative efficacy against MMPs was observed against steroidal and non-steroidal drugs.

Conclusions:

  • Inhibition of MMPs is a therapeutic strategy for diseases like cancer.
  • The Aspergillus fumigatus extract shows promise for developing novel anti-MMP therapeutic derivatives.
  • This extract could be a valuable source for anti-cancer drug development.